Meeting
2023 ASCO Annual Meeting
Longitudinal transcriptome profiling of localized hormone-sensitive tumors in treatment-naïve ENACT patients with prostate cancer with and without enzalutamide (ENZA).
Authors
Ashley Ross
Northwestern University Feinberg School of Medicine, Chicago, IL
Ashley Ross , Neal D. Shore , Elai Davicioni , Xin Zhao , Dina Elsouda , Yang Liu , James A. Proudfoot , John Hairston , David Russell , Kenneth K. Iwata , Edward M. Schaeffer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT02799745
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5026)
DOI
10.1200/JCO.2023.41.16_suppl.5026
Abstract #
5026
Poster Bd #
120
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Comparative genomic analyses between Asian and Caucasian prostate cancers in an 80,829 patient cohort.
First Author: Adelene Sim Yen Ling
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa
Poster
2020 Genitourinary Cancers Symposium
Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy.
First Author: Pai-Chi Teng
Poster
2017 ASCO Annual Meeting
A randomized study of enzalutamide in patients with localized prostate cancer undergoing active surveillance (ENACT).
First Author: Neal D. Shore